Security key
00973Y108
AKERO THERAPEUTICS, INC. - Common Stock (AKRO)
CUSIP: 00973Y108
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 82,872,659
- Total 13F shares
- 91,447,334
- Share change
- -751,247
- Total reported value
- $4,342,160,649
- Put/Call ratio
- 32%
- Price per share
- $47.48
- Number of holders
- 260
- Value change
- -$45,116,104
- Number of buys
- 115
- Number of sells
- 127
Report period
Q3 2025
Institutions
260
Top holders
10
Broader feeds
Reporting periods
Holder history for CUSIP 00973Y108
Recent filing periods:
Top shareholders of AKRO - AKERO THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of AKERO THERAPEUTICS, INC. - Common Stock (AKRO) as of Q3 2025
As of 30 Sep 2025,
AKERO THERAPEUTICS, INC. - Common Stock (AKRO) was held by
260 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
91,447,334 shares.
The largest 10 holders included
JANUS HENDERSON GROUP PLC, GENERAL ATLANTIC, L.P., BlackRock, Inc., RTW INVESTMENTS, LP, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, Deep Track Capital, LP, Avoro Capital Advisors LLC, PRICE T ROWE ASSOCIATES INC /MD/, and STATE STREET CORP.
This page lists
261
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
253
Q3 2025 holders
260
Holder diff
7
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.